Literature DB >> 1451320

Leukonychia due to cytostatic agents.

P Unamuno1, E Fernández-López, C Santos.   

Abstract

Chromonychia induced by antineoplastic agents has been known for several years. The most frequent of these is melanonychia, either diffuse or in tranverse or longitudinal bands, that may co-exist with diffuse pigmentation of the skin. Although any cytostatic agent may be involved in melanonychia, this condition appears most commonly after treatment with adriamycin and cyclophosphamide or in polychemotherapy. Leukonychia, either true or apparent, seems to be less frequent and is the reason for our reporting two patients with this colour change.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1451320     DOI: 10.1111/j.1365-2230.1992.tb02166.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

1.  Orange-brown chromonychia, a novel finding in Kawasaki disease.

Authors:  Priyankar Pal; Prabhas Prasun Giri
Journal:  Rheumatol Int       Date:  2012-09-15       Impact factor: 2.631

2.  Chromonychia secondary to chemotherapy.

Authors:  Marien Lopes; Clarice Jordão; Rachel Grynszpan; Celso Sodré; Marcia Ramos-E-Silva
Journal:  Case Rep Dermatol       Date:  2013-06-06

Review 3.  Leukonychia: What Can White Nails Tell Us?

Authors:  Matilde Iorizzo; Michela Starace; Marcel C Pasch
Journal:  Am J Clin Dermatol       Date:  2022-02-02       Impact factor: 7.403

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.